Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0191120100250050723
Journal of Korean Medical Science
2010 Volume.25 No. 5 p.723 ~ p.727
Effects of Cyclosporin A Therapy Combined with Steroids and Angiotensin Converting Enzyme Inhibitors on Childhood IgA Nephropathy
Shin Jae-Il

Lim Beom-Jin
Kim Pyung-Kil
Lee Jae-Seung
Jeong Hyeon-Joo
Kim Ji-Hong
Abstract
To evaluate the effects of cyclosporin A (CyA) on clinical outcome and pathologic changes in children with IgA nephropathy (IgAN), we retrospectively evaluated 14 children (mean age 8.9¡¾2.9 yr; eight males, six females) who were treated with CyA and steroids. The starting dose of CyA was 5 mg/kg per day, and the drug level was maintained at 100-200 ng/mL. The mean CyA level was 183.8¡¾48.3 ng/mL (range 120.7-276.0 ng/mL) and the mean duration of CyA therapy was 10.9¡¾1.9 months (range 8-12 months). After CyA therapy the mean 24 hr urinary protein excretion declined from 107.1¡¾35.1 mg/m2/hr to 7.4¡¾2.4 mg/m2/hr (P<0.001) and serum albumin increased from 3.3¡¾0.6 g/dL to 4.3¡¾0.3 g/dL (P<0.001). At a follow-up biopsy the histological grade of IgAN was improved in seven (50%) of the 14 patients, remained the same in three (21%), and was aggravated in four (29%). Serum creatinine, creatinine clearance, and blood pressure did not differ before and after CyA therapy. Two patients (14%) showed CyA-induced nephrotoxicity at the second biopsy. Our findings indicate that CyA therapy may be effective in reducing proteinuria and regressing renal pathology in a subset of children with IgAN.
KEYWORD
Glomerulonephritis, IGA, Cyclosporine, Heavy Proteinuria, Child
FullTexts / Linksout information
  
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø